查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088489

神經診斷市場：按設備類型、技術、應用和最終用戶分類 - 全球市場預測（2026-2032 年）

Neurodiagnostics Market by Device Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，神經診斷市場將成長至 249.2 億美元，複合年成長率為 7.65%。

主要市場統計數據
基準年（2025 年） 148.7億美元
預計年份（2026年） 159.7億美元
預測年份（2032年） 249.2億美元
複合年成長率（） 7.65%

神經診斷市場執行摘要

神經診斷領域正從分散的、以醫院為中心的檢查轉向對大腦、神經、肌肉和睡眠障礙進行互聯互通、數據豐富的評估。腦電圖 (EEG)、肌電圖 (EMG)、神經傳導研究、誘發電位測試、多導睡眠圖和術中神經監測等關鍵診斷方法正日益得到雲端平台、穿戴式感測器、遠端監測工具和先進分析技術的支持。

神經診斷領域的變革性變化

神經診斷領域正經歷三大結構性變革：臨床環境的轉變、數位化工作流程的整合以及實證專業化。門診腦電圖、家庭睡眠監測和遠端監測正在減少住院患者對檢查室的依賴，而醫院則優先採用能夠整合訊號擷取、解讀、報告、存檔和電子健康記錄的互操作系統。

人工智慧在神經診斷領域的累積影響

在神經診斷領域，人工智慧（AI）正從實驗階段邁向具有累積影響的階段。在腦電圖（EEG）方面，AI驅動的事件檢測、癲癇模式識別、偽跡減少和分流功能將使臨床醫生能夠更有效率地審查長期記錄。在睡眠診斷方面，自動評分將加快多導睡眠圖的解讀，並且神經肌肉和影像學相關分析可以與專家臨床審查結果進行檢驗，從而提高模式檢測的準確性。

神經學診斷中的區域性因素

亞太地區發展迅速，這得益於其龐大的患者群體、不斷擴展的醫院網路以及國家級數位醫療計劃。在中國、日本、印度、韓國和澳大利亞，人工智慧在癲癇、失智症、中風、神經肌肉疾病和睡眠醫學等領域的應用正在不斷推進。北美地區則憑藉其先進的神經系統基礎設施、獲得FDA已通過核准的技術、完善的保險報銷機制、高密度的臨床試驗以及對攜帶式腦電圖、睡眠診斷和術中神經監測的強勁需求，保持著高度發達的水平。

主要集團戰略經濟聯盟分析

東協地區的需求主要受非傳染性疾病負擔加重、私立醫院擴張以及新加坡、馬來西亞、泰國、印尼、越南和菲律賓等國數位化醫療舉措，這些因素共同促成了對便捷的腦電圖、睡眠研究和神經肌肉檢測的需求。海灣合作理事會（GCC）成員國正投資建設先進醫院、專科神經病學中心和人工智慧驅動的醫療基礎設施，這為高階神經診斷系統、臨床服務夥伴關係以及管理式診斷模式創造了機會。

主要國家神經系統診斷領域的發展趨勢

在美國，主要大學附屬醫療中心、綜合醫療服務網路、FDA核准流程以及對腦電圖、睡眠診斷、肌電圖、神經傳導研究和術中神經監測的需求，正在推動神經診斷技術的普及。加拿大受益於公共醫療保險、學術神經病學網路以及遠距神經病學的擴展。同時，墨西哥和巴西正透過投資私人醫療保健和增加專科中心來擴大服務覆蓋範圍。英國、德國、法國、義大利和西班牙將強大的臨床神經病學能力與嚴格的證據、採購和資料保護要求相結合。在俄羅斯，儘管市場准入和供應鏈複雜，但對醫院神經診斷的需求仍然強勁。

為神經診斷行業的領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的神經診斷平台，這些平台能夠提升處理能力、診斷可靠性、互通性和專家工作效率。產品策略應著重於攜帶式腦電圖 (EEG)、居家睡眠監測、遠端患者監護、雲端閱片、自動化報告以及人工智慧驅動的工作流程工具，這些工具需展現出可衡量的時間節省、可重複性和品質提升。

分析方法

本報告採用系統性的二手資料調查方法，利用檢驗的公開資訊資訊來源、監管資訊、臨床指南、流行病學證據和市場趨勢訊號。輸入資訊包括世界衛生組織 (WHO)、美國疾病管制與預防中心 (CDC)、美國食品藥物管理局 (FDA)、歐洲法規結構、國家衛生機構、神經病學和睡眠醫學專業協會、醫院採購文件以及同行評審的醫學文獻等公開來源。

結論

隨著神經系統疾病負擔日益加重，醫療系統對更早、更快速、更方便的評估工具的需求不斷成長，神經診斷領域正步入持續現代化的階段。最大的商業機會在於互聯診斷、人工智慧驅動的觀察解讀、攜帶式檢測、居家睡眠評估以及能夠幫助專家應對日益複雜病例的工作流程平台。

目錄

第1章 引言

第2章 分析方法

  • 分析設計
  • 分析框架
  • 市場規模預測
  • 數據三角測量
  • 分析結果
  • 分析的前提條件
  • 分析的局限性

第3章執行摘要

  • 首席體驗長的觀點
  • 市場規模和成長趨勢
  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入（GTM）策略

第5章 市場洞察

  • 消費者分析與最終用戶觀點
  • 消費者體驗基準測試
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 成本效益分析（ROI）和成本效益分析（CBA）

第6章：人工智慧（AI）的累積影響（2026 年）

第7章：神經診斷市場：依設備類型分類

  • 神經影像設備
    • 磁振造影（MRI）系統
    • 電腦斷層掃描（CT）掃描儀
    • 正子斷層掃描（PET）系統
    • 單光子發射電腦斷層掃描（SPECT）
  • 神經生理裝置
    • 腦電圖（EEG）系統
    • 肌電圖（EMG）系統
    • 用於神經傳導研究（NCS）的設備
    • 誘發電位（EP）系統

第8章：神經診斷市場：依技術分類

  • 侵入性
    • 深電極監測
    • 皮層電位記錄
  • 非侵入性
    • 電生理學
    • 診斷影像

第9章：神經診斷市場：依應用領域分類

  • 阿茲海默症
    • 路易氏體失智症
    • 血管性失智症
  • 腦腫瘤
  • 癲癇
    • 局部性癲癇
    • 整體癲癇
  • 多發性硬化症
  • 中風
    • 出血性中風
    • 缺血性中風
  • 創傷

第10章 神經診斷市場：依最終使用者分類

  • 門診部
    • 神經科診所
    • 門診復健中心
  • 診斷中心
    • 醫院營運的診斷中心
    • 獨立診斷中心
  • 居家醫療
  • 醫院
    • 綜合醫院
    • 專科診所
  • 研究機構

第11章：神經診斷市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：神經診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：神經診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析（2025 年）
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析（2025 年）
  • 產品系列分析（2025 年）
  • 基準分析（2025 年）

第15章：公司簡介

  • Advanced Brain Monitoring, Inc.
  • BioSerenity
  • Brainscope Co. Inc.
  • Cadwell Laboratories, Inc.
  • Canon Medical Systems Corporation
  • Compumedics Limited
  • Electrical Geodesics, Inc.
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corporation
  • GE HealthCare Corporation
  • Koninklijke Philips NV
  • Lifelines Neuro Company, LLC
  • Medtronic plc
  • Natus Medical Incorporated
  • NeuroMetrix, Inc.
  • Neurosigma, Inc.
  • NeuroSky, Inc.
  • Neurosoft
  • Nicolet Neurodiagnostic Products, Inc.
  • Nihon Kohden Corporation
  • Persyst Development Corporation
  • Rhythmlink International, LLC
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-030226489D71

The Neurodiagnostics Market is projected to grow by USD 24.92 billion at a CAGR of 7.65% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.87 billion
Estimated Year [2026] USD 15.97 billion
Forecast Year [2032] USD 24.92 billion
CAGR (%) 7.65%

Neurodiagnostics Executive Summary

Neurodiagnostics is moving from episodic, hospital-centered testing toward connected, data-rich assessment of brain, nerve, muscle, and sleep disorders. Core modalities such as electroencephalography (EEG), electromyography (EMG), nerve conduction studies, evoked potentials, polysomnography, and intraoperative neuromonitoring are increasingly supported by cloud platforms, wearable sensors, remote monitoring tools, and advanced analytics.

Demand is grounded in measurable disease burden. The World Health Organization reports that neurological conditions affect billions of people globally and are among the leading causes of disability and illness worldwide, while aging populations are increasing the clinical need for diagnosis and monitoring of dementia, stroke, Parkinson's disease, epilepsy, neuropathy, and sleep disorders. For providers, payers, and medtech leaders, neurodiagnostics is becoming a strategic gateway to earlier detection, longitudinal monitoring, and precision neurology.

Transformative Shifts in the Neurodiagnostics Landscape

The neurodiagnostics landscape is being reshaped by three structural shifts: site-of-care migration, digital workflow integration, and evidence-based specialization. Ambulatory EEG, home sleep testing, and remote monitoring are reducing dependence on inpatient laboratories, while hospitals are prioritizing interoperable systems that connect signal acquisition, interpretation, reporting, archiving, and electronic health records.

Regulatory and clinical expectations are also rising. FDA oversight of medical software, EU Medical Device Regulation requirements, cybersecurity rules, and data privacy frameworks are influencing product design, validation, procurement, and lifecycle management. At the same time, neurologists, sleep specialists, neurophysiologists, and technologists are adopting standardized protocols to improve diagnostic consistency, shorten time to interpretation, and support high-volume neurology practices.

Cumulative Impact of Artificial Intelligence in Neurodiagnostics

Artificial intelligence is becoming cumulative rather than experimental in neurodiagnostics. In EEG, AI-assisted event detection, seizure pattern recognition, artifact reduction, and triage can help clinicians review longer recordings more efficiently. In sleep diagnostics, automated scoring supports faster polysomnography interpretation, while neuromuscular and imaging-adjacent analytics can improve pattern detection when validated against expert clinical review.

The most credible AI value proposition is augmentation, not replacement. Health systems are favoring algorithms with transparent validation, bias assessment, clinical workflow fit, cybersecurity safeguards, and post-market performance monitoring. As multimodal datasets expand, AI is positioned to strengthen longitudinal neurology care by combining signal data, imaging, laboratory results, clinical notes, medication history, and patient-reported outcomes.

Key Regional Insights for Neurodiagnostics

Asia-Pacific is advancing through large patient volumes, expanding hospital networks, and national digital health programs, with China, Japan, India, South Korea, and Australia supporting adoption across epilepsy, dementia, stroke, neuromuscular disease, and sleep medicine. North America remains highly developed due to advanced neurology infrastructure, FDA-cleared technologies, reimbursement pathways, clinical trial density, and strong demand for ambulatory EEG, sleep diagnostics, and intraoperative neuromonitoring.

Latin America is improving access through private hospital investment and telehealth-enabled specialty care, particularly in Brazil and Mexico, where urban centers are expanding diagnostic capacity. Europe is shaped by universal health systems, GDPR, Medical Device Regulation compliance, and strong academic neurology networks that emphasize clinical evidence and standardized care. The Middle East is investing in tertiary hospitals, specialty neuroscience services, and medical tourism hubs, while Africa's opportunity centers on scalable, lower-cost diagnostics, workforce training, mobile health models, and partnerships that expand neurological care beyond major urban centers.

Key Group Insights Across Strategic Economic Alliances

ASEAN demand is supported by rising noncommunicable disease burden, expanding private hospitals, and digital health initiatives in Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, creating need for accessible EEG, sleep, and neuromuscular testing. The GCC is investing in advanced hospitals, specialty neurology centers, and AI-enabled healthcare infrastructure, creating opportunities for premium neurodiagnostic systems, clinical service partnerships, and managed diagnostic models.

The European Union emphasizes data protection, clinical evidence, and MDR-compliant innovation, making regulatory readiness and interoperability essential for adoption. BRICS markets combine large neurological patient pools with uneven access to specialists, favoring scalable devices, training programs, tele-neurodiagnostics, and local partnerships. G7 countries lead in research intensity, reimbursement sophistication, specialist availability, and clinical guideline adoption, while NATO countries prioritize resilient health systems, cybersecurity, and deployable medical technologies relevant to military medicine, trauma care, emergency neurology, and rehabilitation.

Key Country Insights in Neurodiagnostics

The United States leads adoption through major academic medical centers, integrated delivery networks, FDA pathways, and demand for EEG, sleep diagnostics, EMG, nerve conduction studies, and intraoperative neuromonitoring. Canada benefits from public health coverage, academic neurology networks, and tele-neurology expansion, while Mexico and Brazil are scaling access through private healthcare investment and growing specialist centers. The United Kingdom, Germany, France, Italy, and Spain combine strong clinical neurology capacity with strict evidence, procurement, and data protection requirements, and Russia maintains demand for hospital-based neurological diagnostics despite market access and supply-chain complexity.

China is expanding neurodiagnostic capacity through hospital modernization, domestic medtech development, and national digital health priorities. India offers high-volume opportunity as neurology access improves across metropolitan and tier-two markets, supported by rising awareness of epilepsy, stroke, neuropathy, and sleep disorders. Japan's aging population supports dementia, stroke, Parkinson's disease, and sleep diagnostics, while South Korea emphasizes digital hospitals, advanced medical technology, and high connectivity. Australia combines strong clinical standards with remote-care needs that favor tele-neurodiagnostics, connected testing models, and specialist access across geographically dispersed communities.

Actionable Recommendations for Neurodiagnostics Industry Leaders

Industry leaders should prioritize clinically validated neurodiagnostic platforms that improve throughput, diagnostic confidence, interoperability, and specialist productivity. Product strategies should focus on ambulatory EEG, home sleep testing, remote patient monitoring, cloud-based review, automated reporting, and AI-enabled workflow tools that demonstrate measurable time savings, reproducibility, and quality improvement.

Commercial execution should align with regional reimbursement, data privacy, cybersecurity, clinical evidence, and procurement realities. Organizations should invest in validation studies, local service networks, technologist training, multilingual user support, and partnerships with neurology, sleep, and surgical monitoring centers. Scalable pricing, modular configurations, and education-led market development can improve adoption in emerging economies while preserving premium positioning in advanced healthcare systems.

Research Methodology

This executive summary applies a structured secondary research methodology using verified public sources, regulatory information, clinical guidelines, epidemiological evidence, and market-facing signals. Inputs include published information from organizations such as the WHO, CDC, FDA, European regulatory frameworks, national health agencies, professional neurology and sleep societies, hospital procurement references, and peer-reviewed medical literature.

Insights were synthesized through triangulation across neurological disease burden, technology adoption, regulatory environment, healthcare infrastructure, workforce availability, reimbursement conditions, and regional access dynamics. The analysis avoids unsupported projections and focuses on evidence-backed drivers shaping neurodiagnostics demand, including aging demographics, neurological disease prevalence, digital health adoption, AI validation requirements, remote-care expansion, and care-delivery transformation.

Conclusion

Neurodiagnostics is entering a period of sustained modernization as neurological disease burden rises and health systems seek earlier, faster, and more accessible assessment tools. The strongest opportunities are linked to connected diagnostics, AI-assisted interpretation, ambulatory testing, home-based sleep assessment, and workflow platforms that help specialists manage increasing case complexity.

Winning organizations will combine clinical rigor with digital scalability. Vendors that prove accuracy, usability, interoperability, privacy protection, cybersecurity, service reliability, and economic value will be best positioned across mature and emerging markets. As neurology becomes more data-driven, neurodiagnostics will remain central to precision care, chronic disease management, surgical safety, and improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Neurodiagnostics Market, by Device Type

  • 7.1. Neuroimaging Devices
    • 7.1.1. Magnetic Resonance Imaging (MRI) Systems
    • 7.1.2. Computed Tomography (CT) Scanners
    • 7.1.3. Positron Emission Tomography (PET) Systems
    • 7.1.4. Single Photon Emission Computed Tomography (SPECT)
  • 7.2. Neurophysiology Devices
    • 7.2.1. Electroencephalography (EEG) Systems
    • 7.2.2. Electromyography (EMG) Systems
    • 7.2.3. Nerve Conduction Study (NCS) Devices
    • 7.2.4. Evoked Potential (EP) Systems

8. Neurodiagnostics Market, by Technology

  • 8.1. Invasive
    • 8.1.1. Depth Electrode Monitoring
    • 8.1.2. Electrocorticography
  • 8.2. Noninvasive
    • 8.2.1. Electrophysiology
    • 8.2.2. Imaging Modalities

9. Neurodiagnostics Market, by Application

  • 9.1. Alzheimer's Disease
    • 9.1.1. Lewy Body Dementia
    • 9.1.2. Vascular Dementia
  • 9.2. Brain Tumor
  • 9.3. Epilepsy
    • 9.3.1. Focal Epilepsy
    • 9.3.2. Generalized Epilepsy
  • 9.4. Multiple Sclerosis
  • 9.5. Stroke
    • 9.5.1. Hemorrhagic Stroke
    • 9.5.2. Ischemic Stroke
  • 9.6. Trauma

10. Neurodiagnostics Market, by End User

  • 10.1. Ambulatory Clinics
    • 10.1.1. Neurology Clinics
    • 10.1.2. Outpatient Rehabilitation Centers
  • 10.2. Diagnostic Centers
    • 10.2.1. Hospital Owned Diagnostic Centers
    • 10.2.2. Independent Diagnostic Centers
  • 10.3. Home Care
  • 10.4. Hospitals
    • 10.4.1. General Hospitals
    • 10.4.2. Specialty Clinics
  • 10.5. Research Institutes

11. Neurodiagnostics Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Neurodiagnostics Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Neurodiagnostics Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Advanced Brain Monitoring, Inc.
  • 15.2. BioSerenity
  • 15.3. Brainscope Co. Inc.
  • 15.4. Cadwell Laboratories, Inc.
  • 15.5. Canon Medical Systems Corporation
  • 15.6. Compumedics Limited
  • 15.7. Electrical Geodesics, Inc.
  • 15.8. F. Hoffmann-La Roche Ltd
  • 15.9. FUJIFILM Holdings Corporation
  • 15.10. GE HealthCare Corporation
  • 15.11. Koninklijke Philips N.V.
  • 15.12. Lifelines Neuro Company, LLC
  • 15.13. Medtronic plc
  • 15.14. Natus Medical Incorporated
  • 15.15. NeuroMetrix, Inc.
  • 15.16. Neurosigma, Inc.
  • 15.17. NeuroSky, Inc.
  • 15.18. Neurosoft
  • 15.19. Nicolet Neurodiagnostic Products, Inc.
  • 15.20. Nihon Kohden Corporation
  • 15.21. Persyst Development Corporation
  • 15.22. Rhythmlink International, LLC
  • 15.23. Siemens Healthineers AG
  • 15.24. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEURODIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NEURODIAGNOSTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NEURODIAGNOSTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NEURODIAGNOSTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEURODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL NEURODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROIMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROIMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROIMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROPHYSIOLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROPHYSIOLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROPHYSIOLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ELECTROENCEPHALOGRAPHY (EEG) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ELECTROENCEPHALOGRAPHY (EEG) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ELECTROENCEPHALOGRAPHY (EEG) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ELECTROMYOGRAPHY (EMG) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ELECTROMYOGRAPHY (EMG) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ELECTROMYOGRAPHY (EMG) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NERVE CONDUCTION STUDY (NCS) DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NERVE CONDUCTION STUDY (NCS) DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NERVE CONDUCTION STUDY (NCS) DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EVOKED POTENTIAL (EP) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL EVOKED POTENTIAL (EP) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL EVOKED POTENTIAL (EP) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DEPTH ELECTRODE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DEPTH ELECTRODE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DEPTH ELECTRODE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ELECTROCORTICOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ELECTROCORTICOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ELECTROCORTICOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NONINVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NONINVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NONINVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ELECTROPHYSIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ELECTROPHYSIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ELECTROPHYSIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IMAGING MODALITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IMAGING MODALITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ALZHEIMER'S DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ALZHEIMER'S DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ALZHEIMER'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LEWY BODY DEMENTIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LEWY BODY DEMENTIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LEWY BODY DEMENTIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VASCULAR DEMENTIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VASCULAR DEMENTIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VASCULAR DEMENTIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BRAIN TUMOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRAIN TUMOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BRAIN TUMOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FOCAL EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FOCAL EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FOCAL EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GENERALIZED EPILEPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GENERALIZED EPILEPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GENERALIZED EPILEPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TRAUMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TRAUMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL TRAUMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AMBULATORY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AMBULATORY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AMBULATORY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROLOGY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEUROLOGY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROLOGY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL OUTPATIENT REHABILITATION CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL OUTPATIENT REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL OUTPATIENT REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HOSPITAL OWNED DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HOSPITAL OWNED DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HOSPITAL OWNED DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL INDEPENDENT DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL INDEPENDENT DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL INDEPENDENT DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 230. GCC NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. GCC NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. GCC NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. GCC NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 234. GCC NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. GCC NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 236. GCC NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 237. GCC NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. GCC NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 239. GCC NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 240. GCC NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 241. GCC NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. GCC NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 243. GCC NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 244. GCC NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 275. G7 NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. G7 NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. G7 NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 278. G7 NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 279. G7 NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. G7 NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 281. G7 NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 282. G7 NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. G7 NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 284. G7 NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 285. G7 NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 286. G7 NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. G7 NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 288. G7 NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 289. G7 NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 290. NATO NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. NATO NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. NATO NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 293. NATO NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. NATO NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. NATO NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 296. NATO NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 297. NATO NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 298. NATO NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 299. NATO NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 300. NATO NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 301. NATO NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. NATO NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 303. NATO NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 304. NATO NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 305. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 321. CANADA NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. CANADA NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. CANADA NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 324. CANADA NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 325. CANADA NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 326. CANADA NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 327. CANADA NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 328. CANADA NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. CANADA NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 330. CANADA NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 331. CANADA NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 332. CANADA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. CANADA NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 334. CANADA NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 335. CANADA NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 336. MEXICO NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 337. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 338. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 339. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 340. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 341. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 342. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 343. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 344. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 345. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 346. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 347. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 348. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 349. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 350. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 351. BRAZIL NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 352. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 353. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY NEUROIMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 354. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY NEUROPHYSIOLOGY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 355. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 356. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 357. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY NONINVASIVE, 2018-2032 (USD MILLION)
  • TABLE 358. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 359. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY ALZHEIMER'S DISEASE, 2018-2032 (USD MILLION)
  • TABLE 360. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
  • TABLE 361. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, 2018-2032 (USD MILLION)
  • TABLE 362. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 363. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 364. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 365. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 366. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 367. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (